Roger Massengale is the CEO of Eitan Group North America, developer of future-ready infusion therapy systems for hospitals, ambulatory & home settings, as well as wearable solutions for easy self-administration. Roger has over 100 patents and has launched products that have generated over $1 billion in medical device sales.
The medical device innovation journey is long and difficult and requires a culture of commitment and foresight that goes beyond the immediate team, extending to all disciplines within the business.